Cite
HARVARD Citation
Choi, W. et al. (2017). Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects. Human vaccines & immunotherapeutics. 13 (7), pp. 1653-1660. [Online].